BioSpace News Archive

Press Releases

Rhythm Pharmaceuticals Reports First Quarter 2025 Financial Results and Business Update

May 7, 2025
·
20 min read
Press Releases

University of Delaware Study Identifies Optimal Formulation of ZIVO’s Active Ingredients for Further Testing to Mitigate Avian Influenza in Poultry

May 7, 2025
·
4 min read
Press Releases

Perfuse Therapeutics Announces Positive Results from the Completed Phase 1/2a Clinical Trial of PER-001 Intravitreal Implant in Patients with Glaucoma

May 7, 2025
·
6 min read
Press Releases

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - May 6, 2025

May 7, 2025
·
2 min read
Press Releases

Adcentrx Therapeutics Granted Fast Track Designation for ADRX-0706 Nectin-4 ADC for the Treatment of Advanced Cervical Cancer

May 7, 2025
·
4 min read
Press Releases

CStone Presents Preclinical Results of CS2011 (EGFR/HER3 bispecific antibody), CS5007 (EGFR/HER3 bispecific ADC), CS5005 (SSTR2 ADC) and CS5006 (ITGB4 ADC) at 2025 AACR

May 7, 2025
·
10 min read
Press Releases

IRLAB Publishes Interim Report for the Period January - March 2025

May 7, 2025
·
9 min read
Press Releases

Evotec Receives $ 2.5 m Grant to Generate Next Generation Tuberculosis Treatments

May 7, 2025
·
4 min read
Press Releases

Dr. Falk Pharma announces positive results from its pivotal phase 3 trial on norucholic acid in primary sclerosing cholangitis

May 7, 2025
·
5 min read
Press Releases

European Commission approves TREMFYA® (guselkumab), the first dual-acting IL-23 inhibitor offering both subcutaneous and intravenous induction options, for adult patients with moderately to severely active Crohn’s disease

May 7, 2025
·
18 min read